Lv12
94 积分 2025-04-16 加入
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
1小时前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
1天前
已完结
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function
7天前
已完结
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
21天前
已完结
JAK Inhibitors in Solid Organ Transplantation
1个月前
已完结
Luminescence of SrAl<sub>2</sub>O<sub>4</sub>:Eu<sup>2+</sup>, Dy<sup>3+</sup> Ceramics Synthesized at Different Firing Condition
1个月前
已完结
Rovadicitinib in Patients with Hemophagocytic Lymphohistiocytosis: A Single Arm, Open-Label, Phase I Study
1个月前
已完结
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study
1个月前
已完结
A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients
3个月前
已完结
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone
3个月前
已完结
皖公网安备34019202002308
